Serum levels of IL-7 in bone marrow transplant recipients: Relationship to clinical characteristics and lymphocyte count

Bone Marrow Transplantation

Volumn 23, Issue 8, 1999, Pages 783-788

  Bolotin, E ^a,b   Annett, G ^a   Parkman, R ^a   Weinberg, K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Bone marrow transplantation; Immune deficiency; Immune reconstitution; Interleukin 7

Indexed keywords

CYTARABINE; DEXAMETHASONE; DOXORUBICIN; INTERLEUKIN 7; TIOGUANINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; THALASSEMIA;

EID: 0032946001     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701655     Document Type: Article

References (43)

1. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
2. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
3. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
4. + T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143-149.
5. Weinberg K, Annett G, Kashyap A et al. The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant 1995; 1: 18-23.
6. Seddik M, Seemayer TA, Lapp WS. T cell functional defect associated with thymic epithelial cell injury induced by a graft-versus-host reaction. Transplantation 1980; 29: 61-66.
7. Desbarats J, Lapp WS. Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med 1993; 178: 805-814.
8. Schalke BC, Mertens HG, Kirchner T et al. Long-term treatment with azathioprine abolishes thymic lymphoid follicular hyperplasia in myasthenia gravis (letter). Lancet 1987; 2: 682.
9. Friedrich W, O'Reilly RJ, Koziner B et al. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood 1982; 59: 696-701.
10. Bengtsson M, Totterman TH, Smedmyr B et al. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 1989; 3: 68-75.
11. Mackall CL, Granger L, Sheard MA et al. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82: 2585-2594.
12. Miller RA, Daley J, Ghalie R, Kaizer H. Clonal analysis of T-cell deficiencies in autotransplant recipients. Blood 1991; 77: 1845-1850.
13. Weinberg K, Hershfield MS, Bastian J et al. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycolmodified adenosine deaminase. J Clin Invest 1993; 92: 596-602.
14. Welte K, Ciobanu N, Moore MA et al. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2. Blood 1994; 64: 380-385.
15. Roux E, Helg C, Dumont-Girard F et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 1996; 87: 3984-3992.
16. Kruger G, Welte K, Ciobanu N et al. Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J Clin Immunol 1984; 4: 295-303.
17. Morrissey PJ, Goodwin RG, Nordan RP et al. Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med 1989; 169: 707-716.
18. Wiles MV, Ruiz P, Imhof BA. Interleukin-7 expression during mouse thymus development. Eur J Immunol 1992; 22: 1037-1042.
19. Welch PA, Namen AE, Goodwin RG et al. Human IL-7: a novel T cell growth factor. J Immunol 1989; 143: 3562-3567.
20. Murray R, Suda T, Wrighton N et al. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol 1989; 1: 526-531.
21. Uckun FM, Tuel-Ahlgren L, Obuz V et al. Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes. Proc Natl Acad Sci USA 1991; 88: 6323-6327.
22. Fabbi M, Groh V, Strominger JL. IL-7 induces proliferation of CD3-/low CD4-CD8-human thymocyte precursors by an IL-2 independent pathway. Int Immunol, 1992; 4: 1-5.
23. Sudo T, Nishikawa S, Ohno N et al. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA 1993; 90: 9125-9129.
24. Muegge K, Vila MP, Durum SK. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 1993; 261: 93-95.
25. Peschon JJ, Morrissey PJ, Grabstein KH et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180: 1955-1960.
26. Grabstein KH, Waldschmidt TJ, Finkelman FD et al. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med 1993; 178: 257-264.
27. Bolotin E, Smogorzewska M, Smith S et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996; 88: 1887-1894.
28. Woods WG, Kobrinsky N, Buckley JD et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 1996; 87: 4979-4989.
29. Oosterwegel MA, Haks MC, Jeffry U et al. Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells. Immunity 1997; 6: 351-360.
30. Lupton SD, Gimpel S, Jerzy R et al. Characterization of the human and murine IL-7 genes. J Immunol 1990; 144: 3592-3601.
31. Tang J, Nuccie BL, Ritterman I et al. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol 1997; 159: 117-125.
32. Morrissey P, Charrier K, Bressler L, Alpert A. The influence of IL-1 treatment on the reconstitution of the hemopoietic and immune systems after sublethal radiation. J Immunol 1988; 140: 4204-4210.
33. Noguchi M, Nakamura Y, Russell SM et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993; 262: 1877-1880.
34. Mempel K, Pietsch T, Menzel T et al. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 1991; 77: 1919-1922.
35. Cairo MS, Suen Y, Sender L et al. Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment. Blood 1992; 79: 1869-1873.
36. Bray GL, Taylor B, O'Donnell R. Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiency. J Pediatr 1992; 120: 528-532.
37. Ascensao JL, Bilgrami S, Zanjani ED. Erythropoietin. Biology and clinical applications. Am J Pediatr Hematol Oncol 1991; 13: 376-387.
38. Ireland RM, Atkinson K, Concannon A et al. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Br J Haematol 1990; 76: 128-134.
39. Lyman SD, Seaberg M, Hanna R et al. Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 1995; 86: 4091-4096.
40. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
41. de Sauvage FJ, Mass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
42. Ballmaier M, Schulze H, Strauss G et al. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood 1997; 90: 612-619.
43. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998; 91: 75-88.